[Alexithymia - an update from a clinical, neurophysiological, and developmental point of view].
This review illustrates the present core findings of alexithymia research. We provide a brief historical background and then show the most important clinical, epidemiological, and psychophysiological findings, focusing on recent EEG and neuro-imaging studies. We describe the neuropsychological and developmental aspects of alexithymia and link them with possible treatment concepts and strategies for outcome evaluation. Finally, suggestions for further empirical research activities are given.
Schäfer
Ralf
R
Klinisches Institut für Psychosomatische Medizin und Psychotherapie, Universitätsklinikum Düsseldorf, Moorenstrasse 5, 40225 Düsseldorf.
Franz
Matthias
M
D000328:Adult; D000342:Affective Symptoms / Q000175:diagnosis / Q000503:physiopathology* / Q000523:psychology / Q000628:therapy*; D000928:Antidepressive Agents / Q000627:therapeutic use; D001143:Arousal / Q000502:physiology; D001921:Brain / Q000503:physiopathology; D001931:Brain Mapping; D002675:Child, Preschool; D015897:Comorbidity; D003866:Depressive Disorder / Q000175:diagnosis / Q000503:physiopathology* / Q000523:psychology / Q000628:therapy*; D004292:Dominance, Cerebral / Q000502:physiology; D004569:Electroencephalography; D004644:Emotions / Q000502:physiology; D006801:Humans; D007223:Infant; D008279:Magnetic Resonance Imaging; D009415:Nerve Net / Q000503:physiopathology; D009769:Object Attachment; D011613:Psychotherapy; D012017:Referral and Consultation; D013001:Somatoform Disorders / Q000175:diagnosis / Q000503:physiopathology* / Q000523:psychology / Q000628:therapy*
D000928:Antidepressive Agents
Alexithymie-ein aktuelles Update aus kilinischer, neurophysiologischer und entwicklunhspsychologischer Sicht.